- Home
- HPH vs OKYO Comparison
HPH vs OKYO Comparison
Compare HPH & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HPH
- OKYO
- Stock Information
- Founded
- HPH 2010
- OKYO 2007
- Country
- HPH China
- OKYO United Kingdom
- Employees
- HPH N/A
- OKYO N/A
- Industry
- HPH
- OKYO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HPH
- OKYO Health Care
- Exchange
- HPH NYSE
- OKYO Nasdaq
- Market Cap
- HPH 31.8M
- OKYO 37.0M
- IPO Year
- HPH 2019
- OKYO 2022
- Fundamental
- Price
- HPH $4.36
- OKYO $1.45
- Analyst Decision
- HPH
- OKYO Strong Buy
- Analyst Count
- HPH 0
- OKYO 1
- Target Price
- HPH N/A
- OKYO $7.00
- AVG Volume (30 Days)
- HPH 85.0K
- OKYO 87.5K
- Earning Date
- HPH 01-01-0001
- OKYO 05-16-2025
- Dividend Yield
- HPH N/A
- OKYO N/A
- EPS Growth
- HPH N/A
- OKYO N/A
- EPS
- HPH N/A
- OKYO N/A
- Revenue
- HPH $286,996,105.00
- OKYO N/A
- Revenue This Year
- HPH N/A
- OKYO N/A
- Revenue Next Year
- HPH N/A
- OKYO N/A
- P/E Ratio
- HPH N/A
- OKYO N/A
- Revenue Growth
- HPH 1722.41
- OKYO N/A
- 52 Week Low
- HPH $3.76
- OKYO $0.81
- 52 Week High
- HPH $558.00
- OKYO $1.74
- Technical
- Relative Strength Index (RSI)
- HPH 39.81
- OKYO 54.76
- Support Level
- HPH $5.02
- OKYO $1.43
- Resistance Level
- HPH $14.00
- OKYO $1.65
- Average True Range (ATR)
- HPH 1.92
- OKYO 0.14
- MACD
- HPH -0.28
- OKYO -0.00
- Stochastic Oscillator
- HPH 0.21
- OKYO 54.39
About HPH HIGHEST PERFORMANCE HLDGS INC
Highest Performances Holdings Inc is a financial technology service group based on family financial asset allocation. The Group operate theree segments: (1) the insurance agency segment, which mainly consists of providing agency services for a wide range of life and non-life insurance products to individual clients, (2) the claims adjusting segment, which consists of providing pre-underwriting survey services, claim adjusting services, disposal of residual value services, loading and unloading supervision services, and consulting services, and (3) the wealth management segment, which mainly consists of providing distribution and managing wealth management services. Maximum revenue is from The Insurance Agency Segment.
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.